Pain News and Research

Latest Pain News and Research

Multiple withdrawal symptoms experienced by people using medical marijuana for chronic pain

More than half of people who use medical marijuana products to ease pain also experience clusters of multiple withdrawal symptoms when they're between uses, a new study finds.

8 Jan 2021

Do-it-yourself contact tracing is a ‘last resort’ in communities besieged by Covid

The contact tracers of Washtenaw County in Michigan have been deluged with work and, to cope, the overburdened health department has a new tactic: It is asking residents who test positive for Covid-19 to do their own contact tracing.

8 Jan 2021

Researchers analyze varying structure of ear canals to improve comfort, efficiency of earplugs

Noise exposure accounts for 22% of worldwide work-related health problems. Excessive noise not only causes hearing loss and tinnitus, but also increases the risk of cardiovascular diseases. T

8 Jan 2021

C-Path PRO Consortium measure now included in FDA-approved label claim

Critical Path Institute's (C-Path) Patient-Reported Outcome (PRO) Consortium announces that clinical study results using the Consortium's Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C) were recently included in the expanded label for the drug LINZESS® (linaclotide).

7 Jan 2021

Virtual care during COVID-19 delivers impressive benefits for cancer patients, clinicians

Patients and healthcare providers at the Princess Margaret Cancer Centre rated virtual care during COVID-19 as highly satisfactory overall for quality of care and convenience, while at the same time saving patients millions in costs.

7 Jan 2021

Link between fever, diarrhea, severe COVID-19, and persistent anti-SARS-CoV-2 antibodies

A new preprint research paper appearing on the medRxiv server describes a link between the persistence of neutralizing antibodies against the virus, disease severity, and specific COVID-19 symptoms.

7 Jan 2021

Study opens the way for a potential new cure for children with hard-to-treat neuroblastoma

Researchers at the University of Gothenburg now suggest a possible cure for children with hard-to-treat forms of neuroblastoma using a new combination of drugs.

7 Jan 2021

CytoDel successfully delivers neuronal antibody in animal models of botulism

CytoDel, Inc., a privately-held corporation, today announces the publication of preclinical data on the Company's lead product, Cyto-111, in the peer-reviewed journal, Science Translational Medicine. The complete text of the article titled, "Neuronal Delivery of Antibodies has Therapeutic Effects in Animal Models of Botulism," can be found here.

7 Jan 2021

Researchers examine effective treatments for victims struggling with chronic pain and PTSD

Post-traumatic stress disorder, or PTSD, affects many people who are exposed to extreme situations, such as torture. Recent research suggests that chronic pain may make it more difficult to treat trauma

7 Jan 2021

Opioid use may increase the risk of pancreatic cancer

Researchers at Rush University Medical Center have found that opioid use might increase a person's risk of developing pancreatic cancer.

6 Jan 2021

Study shows durable specific humoral immunity against SARS-CoV-2 after mild or asymptomatic infection

As a part of the COMMUNITY (COVID-19 Immunity) study, researchers from Sweden reveal long-lasting IgG neutralizing antibody response against spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the vast majority of convalescent individuals – even after asymptomatic or mild infection. Their results are currently available on medRxiv* preprint server.

6 Jan 2021

Mindfulness can help ease neuropathic pain related to breast cancer treatment

A study led by University of Ottawa researchers provides empirical evidence that mindfulness has a significant impact on the brain of women suffering from neuropathic pain related to breast cancer treatment.

6 Jan 2021

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that RHB-204 has been granted Fast Track designation by the U.S. Food and Drug Administration for its development as a potential first-line, stand-alone, oral treatment of pulmonary nontuberculous mycobacteria (NTM) disease caused by Mycobacterium avium Complex (MAC) - a rare disease for which there is no FDA-approved first-line therapy.

6 Jan 2021

Novel technique could replace clinical biopsies with 'virtual biopsies' in future

A new advanced computing technique using routine medical scans to enable doctors to take fewer, more accurate tumor biopsies, has been developed by cancer researchers at the University of Cambridge.

6 Jan 2021

Smokers at increased risk of developing symptomatic COVID-19

Smoking is associated with an increased risk of COVID-19 symptoms and smokers are more likely to attend hospital than non-smokers, a study has found.

6 Jan 2021

Children’s hospitals grapple with wave of mental illness

Krissy Williams, 15, had attempted suicide before, but never with pills.

6 Jan 2021

Mid-term clinical trial results of two cell therapies for critical limb ischemia show similar outcomes

Mid-term results of the first clinical trial designed specifically to evaluate the safety and effectiveness of two cell therapies that are showing early promise in treating angiitis-induced critical limb ischemia were released today in STEM CELLS Translational Medicine.

5 Jan 2021

Pain News and Research

Latest Pain News and Research

Multiple withdrawal symptoms experienced by people using medical marijuana for chronic pain

Do-it-yourself contact tracing is a ‘last resort’ in communities besieged by Covid

Researchers analyze varying structure of ear canals to improve comfort, efficiency of earplugs

C-Path PRO Consortium measure now included in FDA-approved label claim

Virtual care during COVID-19 delivers impressive benefits for cancer patients, clinicians

Link between fever, diarrhea, severe COVID-19, and persistent anti-SARS-CoV-2 antibodies

Study opens the way for a potential new cure for children with hard-to-treat neuroblastoma

CytoDel successfully delivers neuronal antibody in animal models of botulism

Researchers examine effective treatments for victims struggling with chronic pain and PTSD

Opioid use may increase the risk of pancreatic cancer

Study shows durable specific humoral immunity against SARS-CoV-2 after mild or asymptomatic infection

Mindfulness can help ease neuropathic pain related to breast cancer treatment

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

Novel technique could replace clinical biopsies with 'virtual biopsies' in future

Smokers at increased risk of developing symptomatic COVID-19

Children’s hospitals grapple with wave of mental illness

Mid-term clinical trial results of two cell therapies for critical limb ischemia show similar outcomes

Increased pollen counts may trigger symptom flares in patients with urologic chronic pelvic pain syndrome

Covid ‘decimated our staff’ as the pandemic ravages health workers of color in US

Revision of WHO guideline on ensuring balance in national policies for safe use of controlled substances

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Pain News and Research

Latest Pain News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in